About Us

Welcome.

In the USC Westside Center for Diabetes, we change lives —  daily. Led by internationally respected diabetes expert Anne L. Peters, MD, we specialize in treatment of diabetes in adolescents and adults.

As part of a leading research Univesrsity and supported by our philanthropic partners, we offer:

• Intensive diabetes management for type 1 and type 2 diabetes

• Cutting-edge insulin pump therapy and continuous glucose monitoring

• Bilingual diabetes education and nutritional counseling

• Access to the latest research studies

Our involvement in cutting-edge clinical trials and technologies is changing how diabetes is treated, and our community outreach is bringing new tools to residents of underserved areas.

Anne Peters, MD

Director, USC Westside Center for Diabetes

Professor, Keck School of Medicine of USC

Director, USC Clinical Diabetes Programs

Anne L. Peters, MD, is one of the world’s leading diabetes clinicians and clinical researchers and an influential advocate and policy advisor for new diabetes treatment guidelines and increased access to care. Dr. Peters is dedicated to bringing cutting-edge diabetes care to all walks of life, including an underserved lower-literacy population.

She works with the L.A. County Department of Health Services on a county-wide diabetes program, and she established the Community Diabetes Initiatives Research Center (CDI) with Children’s Hospital Los Angeles (CHLA). Dr. Peters received the American Diabetes Association (ADA) Outstanding Physician Clinician Award and the Bernardo Houssay Award from the National Minority Quality Forum for her work with the underserved.

She earned her MD from Pritzker School of Medicine, University of Chicago, and completed an internal medicine residency at Stanford University and an endocrinology fellowship at Cedars-Sinai Medical Center.

Dr. Peters has been a Principal Investigator on multiple clinical trials, including two current grants supported by the National Institutes of Health (NIH), and several active foundation-funded grants. She also serves as special consultant to the U.S. Food & Drug Administration on the development of devices for diabetes treatment.

A sought-after speaker and thought leader, she plays a central role in developing national guidelines for diabetes care, serving on the American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) Guidelines Committee for Management of Type 1 Diabetes. She also participates on the ADA Guidelines Committee for Management of Type 1 Diabetes and the EASD/ADA Committee on Device Safety, and chairs the Endocrine Society Committee on the Use of Devices in Treatment of Diabetes.

Dr. Peters has authored more than 200 articles, reviews and abstracts in peer-reviewed medical journals, as well as three books on diabetes. These include the patient-centered Conquering Diabetes: A Cutting-Edge, Comprehensive Program for Prevention and Treatment and the ADA/JDRF Type 1 Diabetes Sourcebook for health professionals. On track for 2017 is The Type 1 Diabetes Self-Care Manual: A Complete Guide Across the Lifespan for People with Diabetes, Parents, and Caregivers.

In addition, Dr. Peters is a regular contributor to Medscape (the professional side of WebMD) with her video series “Peters on Diabetes.

 

Donna Miller, MSN, FNP-C, CDE

Nurse Practitioner/Certified Diabetes Educator

Donna Miller is dedicated to teaching her patients at the USC Westside Center for Diabetes the self-management skills they need to live successfully with diabetes. Born in Hollywood, Donna grew up in Hawthorne. Prior to joining us as Nurse Practitioner and Certified Diabetes Educator, she gained invaluable experience in heart health (and its links with diabetes). She established and managed the Congestive Heart Failure/Hypertension Center at Daniel Freeman Memorial Hospital.

Her current clinical interests include the physiology and treatment of type 1 and type 2 diabetes across the lifespan. Donna sees a wide range of patients, from pre-teens to geriatric patients and every age in between. One of her areas of expertise is working with women who have type 1 diabetes throughout their pregnancies, from pre-conception on.

“My No. 1 goal is to keep people healthy,” says Donna, “and enjoying the best possible quality of life.”

Valerie Ruelas, MSW, LCSW

Director, Community Diabetes Initiative (CDI),

Children’s Hospital Los Angeles and USC Keck School of Medicine

 

Valerie Ruelas manages research grants and projects for the Community Diabetes Initiative and the Westside Center for Diabetes. She’s an expert in community participation research, assessing local needs to reduce obesity and related chronic conditions like diabetes, primarily among low-income Latinos.

Valerie earned her Masters of Social Work at California State University, Fresno, and is a licensed clinical social worker. Prior to joining WCD, she worked at the L.A. County Department of Health Services, including for LAC+USC Medical Center, the Office of AIDS Programs and Policy and the Maternal, Child and Adolescent Health Programs.

In her community work, Valerie has helped to open a farmer’s market in Watts, teach nutrition and healthy cooking in East L.A., and develop bilingual, low-literacy educational materials about diabetes. She says, “With powerful community-based research, we can reduce obesity and diabetes and improve quality of life.”

Mark Harmel earned his Master of Public Health at the Keck School of Medicine of USC. His roles at the USC Westside Center for Diabetes are to provide diabetes education and is the  coordinatore new of research studies from at the Westside office. He also manages the ongoing TrialNet and T1D Exchange Registry and TrialNet studies.

Mark has a BA in Social Sciences (and studied photography) from Thomas Jefferson College at Grand Valley State University in Michigan, where he grew up. He started his career in 1985 as a photojournalist for newspapers and magazines and evolved to being aprofessional  healthcare photographer.

Of his work at the WCD, he says, “I get to help patients with their current diabetes management and work on research that can change policies and move the science forward to improve care.”

Mark Harmel, MPH, CDE

Certified Diabetes Educator

Research Coordinator

Meg Werner Moreta, MS, RD, CDE

Registered Dietitian/Certified Diabetes Educator

 

Meg Werner Moreta has guided people toward healthy choices for more than two decades. She earned her MS in Human Nutrition at the University of New Haven and a BS in Nutritional Science from California Polytechnic State University, San Luis Obispo. She completed a Dietetic Internship at the University of Medicine and Dentistry of New Jersey.

At WCD, she is responsible for nutritional counseling, pre-pregnancy planning, behavioral therapy and insulin therapy. Meg, who grew up in Manhattan Beach, first joined the WCD staff from 2001-2005, then returned to us several years ago. She has also worked in the Cedars-Sinai Medical Center Diabetes Center and served as a nutritional consultant for TV shows, restaurants and in private practice.

“After working in a hospital environment for five years,’ she says, “I wanted to leave acute care and change direction to outpatient diabetes, where I could make a difference in people’s lives.”

Research and Advocacy

Academic Publications

We work on several fronts to change the future of diabetes care, from testing innovative medications and devices to developing preventive strategies that stop diabetes from developing.

Backed by the National Institutes of Health (NIH), we are a study site on the benefits of Vitamin D on diabetes prevention. In addition, we are in our 12th year in the LookAHEAD study, an Intensive Lifestyle Intervention focused on weight loss achieved through healthy eating and increased physical activity in overweight and obese individuals with type 2 diabetes. We have been able to contrubute contribute to these major national studies by enrolling residents from the Latino resident population we serve at Roybal Comprehensive Health Center in East Los Angeles.

Access  Other studies give our patients early access to new solutions. These include the T1D Exchange Network, which is testing a closed-loop insulin delivery system, along with clinical trials that are analyzing a continuous glucose monitor (CGM) in seniors and in family members without diabetes. We are one of the first centers to test the new Dexcom G6 CGM sensor, and we’re part of TrialNet, an international network exploring how type 1 diabetes can be prevented. We are also currently conducting a study on a potentially better way of using inhaled and a study using a closed-loop CGM/insulin pump system is scheduled for next year.

Advocacy   Dr. Peters is leading an effort to change the Centers for Medicare & Medicaid Services (CMS) policy for insulin pump approval for seniors and has lobbied to convince CMS to fund CGMs for seniors and people with Medicaid.

Prevention   We are committed to studying how lifestyle approaches —  diet, exercise and weight loss —  may improve long-term health outcomes. Our team conducts on-the-ground research to help whole neighborhoods become healthier, including establishing and studying the impact of farmer’s markets.

 

 

Dear Friends,

This officially marks the six-year anniversary of the USC Westside Center for Diabetes (WCD) bi-annual newsletter. If you made it this far, you know that we have made the move to publishing the newsletter on the clinic website. This also allows you to view the content from the summer newsletter and quickly find links to my Medscape videos and academic papers. Let us know how this works for you, as this is a service we provide for your benefit.

November is National Diabetes Month and it is a time to reassess one’s own diabetes status. As I reflect both on all that we have done to improve the lives of people with diabetes, as well as how far we have yet to go; I promise to not give up on pushing the envelope for research and support in this area, and I ask that you do the same. The importance of proper insulin management, overall wellness, educational programs, research studies, and adequate health coverage for this disease is what I fight for every day. I thank all of you who have donated to the cause over the years as you have gifted me the opportunity to make medical advancements in ways others cannot. Our work is far from being done; we must never give up!

We don’t have a donation envelop tucked inside of a physical newsletter, but you can still mail in a check or use a credit card to make an online donation.

I’m proud to announce the launch of my new book, The Type 1 Diabetes Self-Care Manual: A Complete Guide to Type 1 Diabetes Across the Lifespan. This is an in-depth look into the newest methods and tools for living well with Type 1 diabetes that is available for pre-ordering on Amazon and should be available on the ADA site soon as well. It may also make a great holiday gift for someone in your life living with Type 1 Diabetes or for the people who support them. We also have a preview of the book with patient stories.

The most exciting recent news is the FDA approval of the personal Libre continuous glucose monitor and Fiasp, the fastest acting insulin yet. I encourage you to read our updates (and watch the videos) on these developments to learn how they may benefit you or your loved one with diabetes.

On another note, I feel it necessary to comment on the disappointing “elephant in the room”news—the fact that the two former USC deans (Puliafito) and his replacement (Varma) were both forced to resign due to serious issues, including sexual harassment. I was not surprised by the behavior of Dr. Puliafito, but I had higher expectations of Dr. Varma. As a female, it is discouraging to see that the “old boys club” was alive and well, but I believe these events have prompted change. Our interim dean is now an eminently qualified woman, and our search for a new dean should be long and thorough. We women faculty have created a working group to help facilitate change.

I am optimistic that we will continue to advance the culture at the Keck School of Medicine of USC.  USC is still the best place in Los Angeles to develop and implement diabetes programs—we service patients from all socioeconomic situations.  Any donations I receive go directly to helping our research programs in underserved communities. I think now is the time to grow, not shrink what we’ve created over the past 17 years. In this moment of change, we may have more of a voice than ever before—After all, I am the longest serving female faculty member in the medical school. If nothing else, this shows I am persistent.

My heart is full as I enter this holiday season. I am thrilled with how much we have accomplished and I look forward to achieving more goals in 2018. I wish you and your family a big, happy, healthy and beautiful fall season.  Thank you in advance for your holiday charitable gift, it means so much!

Sincerely,

Anne

 

Read Dr.  Peters' Summer 2017 Message here.

 

Message from the Director

News of the Center

My newest book is a consumer version of the textbook on type 1 diabetes that I wrote for health care providers several years ago and is co-authored with Pediatric Endocrinology Jamie Wood, MD. Some of you may know from her service at Children’s Hospital Los Angeles, she is now at the University Hospital Rainbow Babies and Children’s Hospital in Cleveland, Ohio.

The Type 1 Diabetes Self-Care Manual: A Complete Guide to Type 1 Diabetes Across the Lifespan is a guide for all ages, from infants to 90 year olds. We talk about childhood and adult onset diabetes, transitioning youth, exercise and nutrition, technology, and new and improved treatments. There will be an accompanying website hosted by the American Diabetes Association that will be updated as the evidence and treatments change. The site will be launching soon in conjunction with the November start of Diabetes Awareness Month and a link will be posted as soon as the site is live.

Since Jamie and I learn so much about how to live with diabetes from our patients, we wanted to share their wisdom directly with our readers from those who inspired us to get better every day. I truly have the greatest patients a doctor could ever ask for. I am grateful to all who contributed; it was truly a labor of love.

Here is a sample of the stories that are dear to my heart that you will find in the book.

All the Things I Teach My Children Because I Have Type 1 Diabetes

1. It’s not an excuse for anything. I can do anything. Except the things I can’t do because I’m not 20 anymore - like a cartwheel.

2. My children know not to distract me in the morning when I take my insulin; otherwise, I might not remember later that I took my insulin, and then I might take it accidentally twice. That was a sucky day, and I couldn’t drink enough juice to catch up.

3. You really do use math when you grow up.

4. Exercise is really the best medicine - it treats everything!

5. Health insurance is a good perk of employment.

6. Be nice to the smart kids in school. They might cure diabetes when they grow up.

Leslie Kraft, 47 is a physical therapist and mother of two.

I’m Not Diabetes!

After three years of going to camp and meeting others who don’t mind walking around with a pump connected to their waist and their site in their arm or leg, it has shown me that I don’t have to worry about what others possibly think.

Everyone with diabetes probably has something that they hate about it. Probably for me on of my biggest pet peeves is when someone comes up to me and says, “I feel so bad for you, since you have a DISEASE and have to give yourselves shots all the time.” I HATE getting defined that I have a disease! I’m not diabetes, I’m ME!

Ayla Oceanna Kanow, 13 is a competitive soccer player who has had diabetes since age 9.

There Is No Way to Be “Perfect”

Running with type 1 diabetes is always a complicated challenge. Since every run is different, your blood sugar will never act exactly the same each time. The key is knowing you won’t get it right every time and to keep checking your blood sugar to stay on top of any changes. A continuous glucose monitor makes running so much easier I can’t imagine not running without one.

For me, there is always a strong desire to eliminate as many variables as possible: waking up at the same time every day, eating the same thing for breakfast, working out at the same intensity. And while it will make parts of type 1 diabetes less complicated, you’ll never be able to eliminate all the variables and because of that, you’ll never be able to eliminate all of the high and low blood sugars. Once I realized that there was no way to be “perfect,” it let me stop feeling like that was something I had to strive towards. I could live my life the way I wanted to live it without letting type 1 diabetes dictate what I did or didn’t do.

Craig Stubing, 30 is the founder of Type One Run

 

 

The Libre

The first fully fingerstick replacement sensor has been approved by the FDA in September. The Abbott Libre is expected to be available in the US by the end of the year. It was launched in Europe and for the past few years it has been hard to keep up with the demand. Patients love it, but is it right for you?

What it is?

1.  A continuous glucose sensor that is worn on the arm or abdomen.

2.  The user can see what the blood sugar level is by swiping a reader over it.

3. It is factory calibrated - NO fingersticks are required.

4.  The reader shows you a blood sugar level and whether your sugars are rising, falling or staying flat.

5.  It does NOT provide any alarms or alerts when the blood sugar is rising or falling, so the Dexcom or Medtronic sensors may be a better choice for people already on a sensor or who need alerts to low blood sugar levels.

We have experience using the blinded pro-version of the Libre and have been working with patients who have picked up the European version in their travels. For those of you not on a continuous glucose monitor or who dislike doing fingersticks this will be a wonderful option. Ask about a prescription at your next visit if you are interested or visit the Libre website.

Want to know more? Watch the video by Dr. Peters on Medscape:

Faster Acting Insulin

The FDA recently approved Fiasp, a faster acting version of insulin aspart - or Novolog. This insulin starts working more rapidly than Humalog or Novolog, so that it better matches the absorption of food. It also wears off a little more quickly, avoiding some of the low blood sugars seen with the older insulins. It is best suited for patients who use a continuous glucose monitors and are on pre-meal injections or a pump. Although it is not yet approved for pump use, it will be available in either a pen or a vial. It will help with the frustration of being “stuck high” after eating or having to give an insulin injection 15 – 30 minutes before a meal. It can be given immediately before eating or even during the meal. It should be available in the US in January and is priced similar to Novolog.

Want to know more? Watch the video by Dr. Peters on Medscape:

 

 

 

 

 

 

 

 

Community Research: The Kids N Fitness (KNF) program reaches communities throughout the US by partnering with the American Diabetes Association (ADA)

The KNF Program and the ADA have partnered to combat childhood obesity and diabetes this summer in camps and community settings across the country serving over 150 families. Camp PowerUp is designed for children at high risk for type 2 diabetes and their parents to encourage families to engage in fun activities designed to increase nutritional knowledge and empower them to make healthy lifestyle changes. Using an evidence-based curriculum, KNF has been created to reduce the health risks of families participating in the program.

 

After a successful implementation of the KNF curriculum into the PowerUp program, ADA staff members were certified as ADA/KNF trainers to teach new instructors to enable expansion of the program to more families nationwide. The KNF and ADA teams work together to evaluate the effectiveness of the camp experience to ensure successful learning and outcomes for children and their families at the camps and future PowerUp programs.

 

Reunion Cooking Challenge

 

Many families who participated in the 6-week KNF healthy lifestyle program are looking for more information and the KNF staff developed a Reunion Cooking Challenge to reinforce the healthy eating and physical activity. Families returned to create and eat a variety of colorful and healthy dishes. Afterwards the families played kids against parent games that got the heart pumping! Continuing to expand the KNF program is in the works with our Children‘s Hospital of Los Angeles partner.

 

Thanks to our wonderful patients and study participants, we have just completed two clinical trials. One explored a new dosing schedule when using inhaled insulin and the other tested the Dexcom G6 continuous glucose monitor in people without diabetes. We look forward to the results of the studies early next year.

But I can now share that the Dexcom G6 is an improvement that patients will love, they will appreciate the improved accuracy and once a day calibration after warm-up and a smaller transmitter. A big upgrade can also be found in the insertion device. It is a painless, one-button application that will make placement on the arm as easy as the abdomen.

Closed Loop:

We are still scheduled to host a trial of the BigFoot closed-loop system once they finish testing using the Freestyle Libre system as their sensor. We are also being considered for testing other systems as well.

Eastside:

The NIH funded trial using vitamin D to prevent type 2 diabetes is continuing, as is the development of lower literacy English and Spanish training guides for insulin pumps and CGMs.

Now Recruiting

Please see the Pending Clinical Trials page to see if you qualify for our new trials.

 

 

 

Invitation for a study in adults 60 years and older with type 1 diabetes

We are recruiting for a 12-month study in the growing, understudied population of people 60+ with type 1 diabetes. The main goal of the study is to see if using a Dexcom continuous glucose monitor (CGM) can reduce low blood sugar events and improve the quality of life in adults 60 and older with T1D. We will also be looking at the cost issues. The study is called Wireless Innovation for Seniors with Diabetes Mellitus or WISDM.

To qualify for this study:

• You need to be 60 and older and have type 1 diabetes

• Be willing to wear a Dexcom CGM, but have not used one in the past 3-months

• No medical issues that disqualify you from participating

• Can hear CGM alarms

• You can be using either an insulin pump, or multiple daily injections

• Available for 9 or more visits through-out the year

The first 6-months of the study participants will be randomized into either:

• A group using a Dexcom CGM

• A group using a blood glucose meter

Everyone will be using the CGM in the final 6 months of the trial.

Participation is voluntary and all CGM and meter supplies are provided and you will be compensated for your time.

Please contact Mark Harmel at 310-546-6509 or mark@markharmel.com if you are interested or have additional questions.

Eastside:

Effects of Intensive Uric Acid Lowering Therapy with RDEA3170 and Febuxostat in Patients with Albuminuria

Do you have type 2 diabetes and chronic kidney disease? We are looking for people to participate in this study to test an investigational drug for kidney and cardiovascular health. If you qualify, you will be required to come in for 9 study visits. Compensation and transportation is available. Call Sara Serafin-Dokahn for more information or email serafind@usc.edu.

 

 

 

Dear Friends,

When it comes to treating, managing, and researching diabetes, my team and I are leading the movement. In the last two decades we have jumped over many hurdles to advance the quality of diabetes care and increase the availability of much needed medications, pumps and pre-screenings. Our constant and consistent commitment to this cause has undoubtedly saved many lives. The reality of this underrepresented disease is:

• Diabetes is one of the most common diseases in the US; far more so than breast and prostate cancer combined

• Early diagnosis and treatment is the key to living well with diabetes

• The majority of diabetes deaths occur in the lower and middle class communities

• Diabetes is inadequately treated in over half of the people who have it

We have been working hard to provide care to people with diabetes and gain them access to the treatments and the devices they need to live well. Trips to DC to lobby Congress and work with California state legislators and judges have yielded some benefit. However, we have much more to do, as diabetes is one of the largest health threats facing our world today.

Ongoing progress is made possible through research and education. We have multiple new research studies starting up (see box on next page), and are proud to announce that our summer camp nutrition model has been adopted by the ADA and will be piloted in 5 other cities around the country.

None of this progress would exist without your support. We depend on philanthropic gifts to fund our efforts that range from community-based interventions to complex artificial pancreas research. Donations also help provide services in underserved areas that are hardest hit by impending changes in healthcare. In addition to maintaining all of this, my goal is to fundraise a much larger gift of $1.5 million, to launch a program to train nurses and doctors to care for people with diabetes.

Fewer healthcare professionals than ever choose to train in our field of work, and the future of diabetes care is looking grim. I want future generations to have treatment available to them by training and educating professionals to mange this disease with the same care, compassion, knowledge, and respect that we do.

Please help put diabetes prevention and treatment on the map and contribute today. Your gift is tax deductable and will help in a multitude of ways. Thank you for being one of our heroes.

Sincerely,

Anne

For women with type 1 diabetes (T1D) planning a family, the best time to see your endocrinology team is before you get pregnant, not after — at least three to six months before, says Donna Miller, MSN, FNP-C, CDE, Nurse Practitioner and Certified Diabetes Educator at the Westside Center for Diabetes.

One of Donna’s specialties is working with women who have T1D throughout their pregnancies, from pre-conception on. For many years, women with T1D were advised not to get pregnant, she notes. Although it represents more challenges for women with T1D, a healthy pregnancy is entirely possible with careful preparation. “It’s important to create a plan to minimize the risk of complications and maximize the health of the mother and the baby,” says Donna.

High blood glucose at conception and throughout pregnancy can spell added dangers for the baby, including miscarriage and potential birth defects. However, these complications can largely be avoided by intensive glucose management.  “The mothers we see are able to do an amazing job at controlling their blood sugar levels in order to have a successful pregnancy.  We consider it a joy to be able to help mothers bring healthy infants into the world.”

Donna advises her patients to use a continuous glucose monitor (CGM) and insulin pump to get the most accurate, convenient monitoring and delivery of insulin. “Using these devices, the woman can make insulin decisions based on the trending blood glucose,” she says. For women who decide against CGM and a pump, Donna offers other options for managing their pregnancy.

She also works with her patients to develop a nutritional plan, critical for managing the demands of pregnancy. “In some cases, meals you’ve always eaten might not work during pregnancy because they tend to raise your glucose too high.” Exercise — walking and yoga, for example — also are important.

Each pregnancy plan is highly individualized. But one recommendation Donna makes applies to all, she says: interview your potential OB/GYN and perinatologist. “Find out their comfort level and understanding of type 1 diabetes.” The WCD maintains referral lists and can help you find one that works for you.

To begin planning for your healthy pregnancy, contact Donna at the WCD.

New developments in diabetes happen slowly, yet at this year’s annual American Diabetes Association 77th Scientific Sessions there were many glimmers of hope, particularly in the area of new technologies and medications.

Oral, faster, smarter and all-around better insulins were discussed and positive data came out on the safety of the long acting insulin known as degludec (Tresiba) in the DEVOTE Trial.

The biggest news was on the cardiovascular benefits of a medication known as canagliflozin (Invokana) which showed benefit in terms of reducing heart disease risk.  This supports the previous findings for empagliflozin (Jardiance) suggesting that all the medications in this class known as “SGLT-2 inhibitors” may have cardiovascular benefit.

Dr. Peters presented on four topics; updating the diabetes guidelines, continuous glucose monitoring safety, the new diabetes medication known as sotagliflozin (for people with both type 1 and type 2 diabetes) and the restrictive nature of current CMS rules regarding insulin pump therapy. Reporting for Medscape, Mark covered the news from the ADA and his videos can be found on-line.

Our WCD team, led by Dr. Peters, is grateful to be able to play a role in the process of advancing treatment for diabetes. We remain hopeful to develop new methods of care and establish higher levels of education for this underrepresented, life-threatening condition.

We lost one of our very special patients recently—Don Rickles —who was a beloved patient, friend and benefactor. Although he was known as an “insult” comic he was the singularly kindest man I have ever known.  Off stage, he made me laugh and always feel loved and valued.  He would, however, admonish me to “leave the jokes to him” if I joked back. I miss him very much. We send our heartfelt condolences to his family and friends. If you would like to donate in honor of Don Rickles and his memory here at WCD, please fill out the envelope and write “Don Rickles” on the in memory line. We will share your gift by sending a notification letter to his wife Barbara and family in your honor.

— Anne

 

The first version of the House ACHA health bill just stalled and the Presidential budget with major cuts in health research funding was released right before Mark made his first trip joining the American Diabetes Association’s Call to Congress lobbying event in Washington D. C. The agenda in March was filled with pressing topics from rising insulin prices to increasing concerns about insurance coverage for people with preexisting conditions, and the risk of major cuts in funding for medical research and diabetes prevention.

Attending with our patient Doris Gilbert and other ADA Los Angeles advocates, we were joined by over 180 other patient advocates and researchers from 33 states. Our LA group met with staff members from the offices of Senators Harris and Feinstein, plus Representatives Bass, Cardenas, and Barragan to ask for policy changes to prevent diabetes and to improve the lives of our patients.

A highlight happened during one of our policy talks, with a policy staffer from Rep. Cardenas’ office who seemed to be distracted by series of text messages on his phone. We shortly discovered that he was texting his girlfriend – a newly diagnosed type 1 diabetes staffer working in another office who had never met another person with T1D. Policy questions melted in face of personal concerns about living with T1D, but in the process we created two new diabetes advocates.

 

Whether you attend for the family fun or for the TrialNet screening this annual summer event is always a great event for Type 1 diabetes families. Family members are 15 times more likely to develop type 1 diabetes and a simple screening test is accurate at detecting the early stages and provides the gateway for prevention trials.

 

July 16, 2017,

12:00 pm - 3:00 pm Griffith Park,

Crystal Springs Picnic Area

4659 Crystal Springs Drive

Los Angeles, CA 90027

 

We are recruiting for three studies for people with type 1 diabetes and one for people without diabetes at all. Let us know if you want to participate. Contact Mark Harmel at 310-546-6509 or Mark.Harmel@med.usc.edu

STAT Study - Study Comparing Novolog vs Technosphere (inhaled) Insulin

This is a 5-week study of inhaled insulin (Afrezza). We are looking for people aged 18   –   70 years with type 1 diabetes on injection therapy who will be randomized to either staying on shots or switched to inhaled insulin before meals. All participants will wear a Dexcom G5 CGM.

CGM NDS - Assessing Continuous Glucose Sensor Profiles in Healthy Non-Diabetic Subjects

We are looking to figure out what “normal” blood sugars look like in people without diabetes or prediabetes. We need anyone 18 and older who is willing to wear a Dexcom CGM for 10 days and calibrate with a blood glucose meter twice a day. This is a great way for friends and families with diabetes to learn empathy and show support while helping research.

WISDM - Continuous Glucose Monitoring (CGM) in people with T1D over 60 yrs old.

We are looking for people 60 and over with type 1 diabetes who have not used a CGM in the past 3 months and would like to be on one. In this 12-month study people will be randomized to continuing fingersticks or using the Dexcom CGM for the first 6 months. Everyone will be on CGM for the last 6 months.

Sence Study with Bigfoot Biomedical – Automated insulin delivery system

This study uses the Bigfoot Biomedical smartloop automated insulin delivery system in people with type 1 diabetes. The system uses an insulin pump, CGM and smartphone to read glucose levels and control the delivery of insulin to increase the time spent in a target glucose range. More details to follow, enrolling late Fall/Winter.

 

Make a Difference

Support for diabetes treatment and prevention is precarious. Funding goes disproportionately to cancer and heart disease. Yet uncontrolled diabetes is a leading cause of heart disease, stroke, kidney disease, blindness, and early death.

In Los Angeles, people in the poorest parts of town have the highest rates of diabetes, obesity and heart disease, as well as fewer doctors and a life expectancy 12 years less (73 vs. 85 years) than those in the wealthiest parts of L.A. These disparities are largely due to diabetes and its related complications.

As our philanthropic partner, you can help improve diabetes care and prevention now and set the stage for future breakthroughs. No gift is too small.

We are currently seeking support for these priority programs:

• Continued development, testing and dissemination of culturally sensitive, lower-literacy diabetes educational tools

• Innovative pilot projects in the communities of East and South L.A. aimed at reducing rates obesity and diabetes

• Development of a training program for nurses, nurse practitioners, and physician fellows to treat patients with diabetes — vitally important given a growing shortage of expert practitioners

• Research into an artificial pancreas for type 1 diabetes, which has the potential to free patients from the roller-coaster cycle of high and low blood sugar

• Advocacy work to:
1) convince health insurers (including Medicare) to pay for needed diabetes tools and treatments,
2) persuade the FDA to adopt more realistic outcome goals for developing diabetes medications, and
3) meet with Congressional Representatives to influence research and healthcare policy

“We hope that those who can afford it will pay it forward to help us in our efforts to improve outcomes for all.”  
— Anne Peters, MD

 

Make an on-line donation at: www.keck.usc.edu/donatewcd
or send a check to: USC Westside Center for Diabetes
150 N. Robertson Blvd.
Suite 210
Beverly Hills, CA 90211

Valerie Ruelas,

Program Director, 323-361-8416

Thank you for your interest and your support.

Our Funding Goals

$10,000,000

endows the program and continues

our work indefinitely

$1,500,000

trains 5 physician fellows in

diabetes over 10 years

$500,000

supports our programs for

families and youth for three years

$200,000

develops and disseminates

our type 1 diabetes tools

We want to hear from you.

If you have any questions or want to make an appointment, please use this form.
Or simply call us at 310-272-8222 or email us.

Submitting Form...

The server encountered an error.

Form received.

USC Westside Center for Diabetes

9033 Wilshire Blvd., Suite 406

Beverly Hills, CA 90211

tel. 310-272-8222 ext. 0

fax. 310-272-8206

News of the Center

Thanks to our wonderful patients and study participants, we have just completed two clinical trials. One explored a new dosing schedule when using inhaled insulin and the other tested the Dexcom G6 continuous glucose monitor in people without diabetes. We look forward to the results of the studies early next year.

But I can now share that the Dexcom G6 is an improvement that patients will love, they will appreciate the improved accuracy and once a day calibration after warm-up and a smaller transmitter. A big upgrade can also be found in the insertion device. It is a painless, one-button application that will make placement on the arm as easy as the abdomen.

Closed Loop:

We are still scheduled to host a trial of the BigFoot closed-loop system once they finish testing using the Freestyle Libre system as their sensor. We are also being considered for testing other systems as well.

Eastside:

The NIH funded trial using vitamin D to prevent type 2 diabetes is continuing, as is the development of lower literacy English and Spanish training guides for insulin pumps and CGMs.

Now Recruiting

Please see the Pending Clinical Trials page to see if you qualify for our new trials.

 

 

 

News of the Center

News of the Center

News of the Center

News of the Center

News of the Center

News of the Center

News of the Center

$10,000,000

endows the program and continues

our work indefinitely

$1,500,000

trains 5 physician fellows in

diabetes over 10 years

$500,000

supports our programs for

families and youth for three years

$200,000

develops and disseminates

our type 1 diabetes tools

News of the Center

News of the Center

News of the Center

News of the Center

News of the Center

News of the Center

News of the Center

News of the Center

$10,000,000

endows the program and continues

our work indefinitely

$1,500,000

trains 5 physician fellows in

diabetes over 10 years

$500,000

supports our programs for

families and youth for three years

$200,000

develops and disseminates

our type 1 diabetes tools

Anne Peters, MD

Director, USC Westside Center for Diabetes

Professor, Keck School of Medicine of USC

Director, USC Clinical Diabetes Programs

Anne L. Peters, MD, is one of the world’s leading diabetes clinicians and clinical researchers and an influential advocate and policy advisor for new diabetes treatment guidelines and increased access to care. Dr. Peters is dedicated to bringing cutting-edge diabetes care to all walks of life, including an underserved lower-literacy population.

She works with the L.A. County Department of Health Services on a county-wide diabetes program, and she established the Community Diabetes Initiatives Research Center (CDI) with Children’s Hospital Los Angeles (CHLA). Dr. Peters received the American Diabetes Association (ADA) Outstanding Physician Clinician Award and the Bernardo Houssay Award from the National Minority Quality Forum for her work with the underserved.

She earned her MD from Pritzker School of Medicine, University of Chicago, and completed an internal medicine residency at Stanford University and an endocrinology fellowship at Cedars-Sinai Medical Center.

Dr. Peters has been a Principal Investigator on multiple clinical trials, including two current grants supported by the National Institutes of Health (NIH), and several active foundation-funded grants. She also serves as special consultant to the U.S. Food & Drug Administration on the development of devices for diabetes treatment.

A sought-after speaker and thought leader, she plays a central role in developing national guidelines for diabetes care, serving on the American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) Guidelines Committee for Management of Type 1 Diabetes. She also participates on the ADA Guidelines Committee for Management of Type 1 Diabetes and the EASD/ADA Committee on Device Safety, and chairs the Endocrine Society Committee on the Use of Devices in Treatment of Diabetes.

Dr. Peters has authored more than 200 articles, reviews and abstracts in peer-reviewed medical journals, as well as three books on diabetes. These include the patient-centered Conquering Diabetes: A Cutting-Edge, Comprehensive Program for Prevention and Treatment and the ADA/JDRF Type 1 Diabetes Sourcebook for health professionals. On track for 2017 is The Type 1 Diabetes Self-Care Manual: A Complete Guide Across the Lifespan for People with Diabetes, Parents, and Caregivers.

In addition, Dr. Peters is a regular contributor to Medscape (the professional side of WebMD) with her video series “Peters on Diabetes.

 

Donna Miller, MSN, FNP-C, CDE

Nurse Practitioner/Certified Diabetes Educator

Donna Miller is dedicated to teaching her patients at the USC Westside Center for Diabetes the self-management skills they need to live successfully with diabetes. Born in Hollywood, Donna grew up in Hawthorne. Prior to joining us as Nurse Practitioner and Certified Diabetes Educator, she gained invaluable experience in heart health (and its links with diabetes). She established and managed the Congestive Heart Failure/Hypertension Center at Daniel Freeman Memorial Hospital.

Her current clinical interests include the physiology and treatment of type 1 and type 2 diabetes across the lifespan. Donna sees a wide range of patients, from pre-teens to geriatric patients and every age in between. One of her areas of expertise is working with women who have type 1 diabetes throughout their pregnancies, from pre-conception on.

“My No. 1 goal is to keep people healthy,” says Donna, “and enjoying the best possible quality of life.”

Valerie Ruelas, MSW, LCSW

Director, Community Diabetes Initiative (CDI),

Children’s Hospital Los Angeles and USC Keck School of Medicine

 

Valerie Ruelas manages research grants and projects for the Community Diabetes Initiative and the Westside Center for Diabetes. She’s an expert in community participation research, assessing local needs to reduce obesity and related chronic conditions like diabetes, primarily among low-income Latinos.

Valerie earned her Masters of Social Work at California State University, Fresno, and is a licensed clinical social worker. Prior to joining WCD, she worked at the L.A. County Department of Health Services, including for LAC+USC Medical Center, the Office of AIDS Programs and Policy and the Maternal, Child and Adolescent Health Programs.

In her community work, Valerie has helped to open a farmer’s market in Watts, teach nutrition and healthy cooking in East L.A., and develop bilingual, low-literacy educational materials about diabetes. She says, “With powerful community-based research, we can reduce obesity and diabetes and improve quality of life.”

Mark Harmel, MPH, CDE

Certified Diabetes Educator

Research Coordinator

Mark Harmel earned his Master of Public Health at the Keck School of Medicine of USC. His roles at the USC Westside Center for Diabetes are to provide diabetes education and is the  coordinatore new of research studies from at the Westside office. He also manages the ongoing TrialNet and T1D Exchange Registry and TrialNet studies.

Mark has a BA in Social Sciences (and studied photography) from Thomas Jefferson College at Grand Valley State University in Michigan, where he grew up. He started his career in 1985 as a photojournalist for newspapers and magazines and evolved to being aprofessional  healthcare photographer.

Of his work at the WCD, he says, “I get to help patients with their current diabetes management and work on research that can change policies and move the science forward to improve care.”

Meg Werner Moreta, MS, RD, CDE

Registered Dietitian/Certified Diabetes Educator

 

Meg Werner Moreta has guided people toward healthy choices for more than two decades. She earned her MS in Human Nutrition at the University of New Haven and a BS in Nutritional Science from California Polytechnic State University, San Luis Obispo. She completed a Dietetic Internship at the University of Medicine and Dentistry of New Jersey.

At WCD, she is responsible for nutritional counseling, pre-pregnancy planning, behavioral therapy and insulin therapy. Meg, who grew up in Manhattan Beach, first joined the WCD staff from 2001-2005, then returned to us several years ago. She has also worked in the Cedars-Sinai Medical Center Diabetes Center and served as a nutritional consultant for TV shows, restaurants and in private practice.

“After working in a hospital environment for five years,’ she says, “I wanted to leave acute care and change direction to outpatient diabetes, where I could make a difference in people’s lives.”

 

About Us

 

 

 

 

 

 

 

 

 

 

 

Welcome.

In the USC Westside Center for Diabetes, we change lives —  daily. Led by internationally respected diabetes expert Anne L. Peters, MD, we specialize in treatment of diabetes in adolescents and adults.

As part of a leading research Univesrsity and supported by our philanthropic partners, we offer:

• Intensive diabetes management for type 1 and type 2 diabetes

• Cutting-edge insulin pump therapy and continuous glucose monitoring

• Bilingual diabetes education and nutritional counseling

• Access to the latest research studies

Our involvement in cutting-edge clinical trials and technologies is changing how diabetes is treated, and our community outreach is bringing new tools to residents of underserved areas.

Message from the Director

Please see the Pending Clinical Trials page to see if you qualify for our new trials.

Message from the Director — Summer 2017

$10,000,000

endows the program and continues

our work indefinitely

$1,500,000

trains 5 physician fellows in

diabetes over 10 years

$500,000

supports our programs for

families and youth for three years

$200,000

develops and disseminates

our type 1 diabetes tools